US FDA Argues Very Few Accelerated Approvals Remain On Market Without Confirmation

 
• By Michael McCaughan
Pill with security shield
FDA's defense of the current accelerated approval system is revealing itself. • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards